RECOMBINANT PROUROKINASE IN ACUTE ISCHEMIC STROKE WITHIN 4.5 HOURS OF STROKE ONSET TRIAL-2 (PROST-2): A PHASE 3, MULTI-CENTRE, OPEN-LABEL, BLINDED-ENDPOINT, RANDOMISED CONTROLLED, NON-INFERIORITY TRIAL

被引：0
|
作者：
Li, S. [1 ]
Gu, H. [1 ]
Feng, B. [1 ]
Wang, Y. [1 ]
机构：
[1] Beijing Tiantan Hosp, Beijing, Peoples R China
来源：
INTERNATIONAL JOURNAL OF STROKE | 2024年 / 19卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
O126 / #3
引用
收藏
页码：57 / 58
页数：2
相关论文
共 50 条
  • [21] Early treatment with aspirin plus extended-release dipyridamole for transient ischaemic attack or ischaemic stroke within 24 h of symptom onset (EARLY trial): a randomised, open-label, blinded-endpoint trial
    Dengler, Reinhard
    Diener, Hans-Christoph
    Schwartz, Andreas
    Grand, Martin
    Schumacher, Helmut
    Machnig, Thomas
    Eschenfelder, Christoph Cyrill
    Leonard, Joachim
    Weissenborn, Karin
    Kastrup, Andreas
    Haberl, Roman
    LANCET NEUROLOGY, 2010, 9 (02): : 159 - 166
  • [22] Tenecteplase versus Alteplase for Stroke Thrombolysis Evaluation Trial in the Ambulance (Mobile Stroke Unit-TASTE-A): protocol for a prospective randomised, open-label, blinded endpoint, phase II superiority trial of tenecteplase versus alteplase for ischaemic stroke patients presenting within 4.5 hours of symptom onset to the mobile stroke unit
    Bivard, Andrew
    Zhao, Henry
    Coote, Skye
    Campbell, Bruce
    Churilov, Leonid
    Yassi, Nawaf
    Yan, Bernard
    Valente, Michael
    Sharobeam, Angelos
    Balabanski, Anna
    Dos Santos, Angela
    Ng, Felix
    Langenberg, Francesca
    Stephenson, Michael
    Smith, Karen
    Bernard, Steve
    Thijs, Vincent
    Cloud, Geoffrey
    Choi, Philip
    Ma, Henry
    Wijeratne, Tissa
    Chen, Chushuang
    Olenko, Liudmyla
    Davis, Stephen M.
    Donnan, Geoffrey A.
    Parsons, Mark
    BMJ OPEN, 2022, 12 (04):
  • [23] Intensive blood pressure control after endovascular thrombectomy for acute ischaemic stroke (ENCHANTED2/MT): a multicentre, open-label, blinded-endpoint, randomised controlled trial (vol 400, pg 1585, 2022)
    Yang, P.
    Song, L.
    Zhang, Y.
    LANCET, 2022, 400 (10367): : 1926 - 1926
  • [24] Intravenous tenecteplase compared with alteplase for acute ischaemic stroke in Canada (AcT): a pragmatic, multicentre, open-label, registry-linked, randomised, controlled, non-inferiority trial
    Menon, Bijoy K.
    Buck, Brian H.
    Singh, Nishita
    Deschaintre, Yan
    Almekhlafi, Mohammed A.
    Coutts, Shelagh B.
    Thirunavukkarasu, Sibi
    Khosravani, Houman
    Appireddy, Ramana
    Moreau, Francois
    Gubitz, Gord
    Tkach, Aleksander
    Catanese, Luciana
    Dowlatshahi, Dar
    Medvedev, George
    Mandzia, Jennifer
    Pikula, Aleksandra
    Shankar, Jai
    Williams, Heather
    Field, Thalia S.
    Manosalva, Alejandro
    Siddiqui, Muzaffar
    Zafar, Atif
    Imoukhuede, Oje
    Hunter, Gary
    Demchuk, Andrew M.
    Mishra, Sachin
    Gioia, Laura C.
    Jalini, Shirin
    Cayer, Caroline
    Phillips, Stephen
    Elamin, Elsadig
    Shoamanesh, Ashkan
    Subramaniam, Suresh
    Kate, Mahesh
    Jacquin, Gregory
    Camden, Marie-Christine
    Benali, Faysal
    Alhabli, Ibrahim
    Bala, Fouzi
    Horn, MacKenzie
    Stotts, Grant
    Hill, Michael D.
    Gladstone, David J.
    Poppe, Alexandre
    Sehgal, Arshia
    Zhang, Qiao
    Lethebe, Brendan Cord
    Doram, Craig
    Ademola, Ayoola
    LANCET, 2022, 400 (10347): : 161 - 169
  • [25] Efficacy and safety of glibenclamide therapy after intracerebral haemorrhage (GATE-ICH): A multicentre, prospective, randomised, controlled, open-label, blinded-endpoint, phase 2 clinical trial
    Zhao, Jingjing
    Song, Changgeng
    Li, Deshuai
    Yang, Xiai
    Yu, Liping
    Wang, Kangjun
    Wu, Jun
    Wang, Xiaofeng
    Li, Dongsong
    Zhang, Bo
    Li, Binyong
    Guo, Jun
    Feng, Weikui
    Fu, Feng
    Gu, Xinrong
    Qian, Jian
    Li, Jialong
    Yuan, Xiangjun
    Liu, Qiuwu
    Chen, Jiang
    Wang, Xiaocheng
    Liu, Yi
    Wei, Dong
    Wang, Ling
    Shang, Lei
    Yang, Fang
    Jiang, Wen
    ECLINICALMEDICINE, 2022, 53
  • [26] Non-immunogenic recombinant staphylokinase versus alteplase for patients with acute ischaemic stroke 4.5 h after symptom onset in Russia (FRIDA): a randomised, open label, multicentre, parallel-group, non-inferiority trial
    Gusev, Eugene, I
    Martynov, Mikhail Yu
    Nikonov, Alexey A.
    Shamalov, Nikolay A.
    Semenov, Michail P.
    Gerasimets, Eugene A.
    Yarovaya, Elena B.
    Semenov, Andrey M.
    Archakov, Alexander, I
    Markin, Sergey S.
    LANCET NEUROLOGY, 2021, 20 (09): : 721 - 728
  • [27] Balloon guide catheters for endovascularthrombectomy in patients with acute ischaemic stroke due to large-vessel occlusion in China (PROTECT-MT): a multicentre, open-label, blinded-endpoint, randomised controlled trial
    Liu, Jianmin
    Zhou, Yu
    Zhang, Lei
    Li, Zifu
    Chen, Wenhuo
    Zhu, Yueqi
    Yao, Xiaoxi
    Zhang, Liyong
    Liu, Shen
    Peng, Ya
    Wei, Ming
    Zhang, Quanbin
    Shu, Hansheng
    Wang, Shouchun
    Liu, Wenhua
    Wan, Shu
    Li, Tong
    Fang, Yibin
    Han, Hongxing
    Zhang, Guang
    Huang, Li'an
    Wang, Feng
    Cheng, Guangsen
    Gao, Lianbo
    Shi, Hongchao
    Han, Jintao
    Luo, Yun
    Li, Shuai
    Cai, Chuwei
    Yin, Rong
    Jin, Zhenglong
    Shao, Chengwei
    Tian, Bing
    Zhang, Yongxin
    Li, Qiang
    Zhang, Yingying
    Zhang, Ping
    Li, Binben
    Xing, Pengfei
    Shen, Hongjian
    Zhu, Xuan
    Zhang, Xiaoxi
    Hua, Weilong
    Shen, Fang
    Huyan, Meihua
    Chen, Rundong
    Zuo, Qiao
    Huang, Qinghai
    Xu, Yi
    Deng, Benqiang
    LANCET, 2024, 404 (10468): : 65 - 74
  • [28] Prehospital transdermal glyceryl trinitrate in patients with presumed acute stroke (MR ASAP): an ambulance-based, multicentre, randomised, open-label, blinded endpoint, phase 3 trial
    van den Berg, Sophie A.
    Venema, Simone M. Uniken
    Reinink, Hendrik
    Hofmeijer, Jeannette
    Schonewille, Wouter J.
    Miedema, Irene
    Fransen, Puck S. S.
    Pruissen, D. Martijn O.
    Raaijmakers, Theodora W. M.
    van Dijk, Gert W.
    De Leeuw, Frank-Erik
    van Vliet, Jorine A.
    Kwa, Vincent I. H.
    Kerkhoff, Henk
    van't Net, Alex
    Boomars, Rene
    Siegers, Arjen
    Lok, Tycho
    Caminada, Klaartje
    Cuevas, Laura M. Esteve
    Visser, Marieke C.
    Zwetsloot, Casper P.
    Boomsma, Jooske M. F.
    Schipper, Mirjam H.
    van Eijkelenburg, Roeland P. J.
    Berkhemer, Olvert A.
    Nieboer, Daan
    Lingsma, Hester F.
    Emmer, Bart J.
    van Oostenbrugge, Robert J.
    van der Lugt, Aad
    Roos, Yvo B. W. E. M.
    Majoie, Charles B. L. M.
    Dippel, Diederik W. J.
    Nederkoorn, Paul J.
    van der Worp, H. Bart
    LANCET NEUROLOGY, 2022, 21 (11): : 971 - 981
  • [29] Early treatment with aspirin and extended-release dipyridamole versus low dose aspirin alone for TIA/ischaemic stroke within 24 hour of symptom-onset (EARLY-trial): a randomised, open-label, blinded-endpoint trial
    Dengler, R.
    Diener, H. C.
    Grond, M.
    Haberl, R.
    Leonard, J.
    Machnig, T.
    Schenkel, J.
    Schumacher, H.
    Schwartz, A.
    Weissenborn, K.
    EUROPEAN JOURNAL OF NEUROLOGY, 2009, 16 : 655 - 655
  • [30] A reduced-dose recombinant pertussis vaccine booster in Thai adolescents: a phase 2/3, observer-blinded, randomised controlled, non-inferiority trial
    Puthanakit, Thanyawee
    Tangsathapornpong, Auchara
    Anugulruengkitt, Suvaporn
    Nantanee, Rapisa
    Bunjoungmanee, Pornumpa
    Mansouri, Souad
    Fortuna, Librada
    Wijagkanalan, Wassana
    Tantawichien, Terapong
    LANCET CHILD & ADOLESCENT HEALTH, 2024, 8 (12): : 900 - 909
12345